The $19.50 figure is my calculation from six identifiable, current analyst price targets rather than an official published consensus. The range is unusually wide — from a low of $10 to a high of $32 — reflecting genuine disagreement about QUBT's valuation. On the bullish side, Ascendiant Capital's Edward Woo raised his target to $32 in late August 2026, Rosenblatt Securities' John McPeake reiterated a $22 target in October 2026 after meetings with management, Lake Street raised its target to $21, and Northland maintained $20. On the cautious side, Cantor Fitzgerald carries a $10 target and Wedbush a $12 target, both with Neutral ratings.
Bullish analysts emphasize that QUBT now has commercial products shipping, from quantum optimization to quantum-secure communications and sensing, and is moving toward chip-scale production with its own TFLN chips. Rosenblatt specifically argues the balance sheet — about $1.32 billion in cash and investments, or $5.67 per share — "remains a strong support for the stock." Neutral firms are more cautious about the still-early revenue base and the path to sustained profitability. This wide spread means the $19.50 mean is a statistical midpoint, not a guarantee. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares closed near $6.86 in early November 2026, within a 52-week range of roughly $5.39 to $14.45. From $6.86, the move to $19.50 represents about 184% upside — a very large move that would require QUBT to more than double the upper end of its recent trading range. The company reported a dramatic third-quarter revenue increase of roughly 2,374% year over year, with quarterly revenue exceeding the $9.2 million generated across the entire first half of 2026, yet the stock still slipped in after-hours trading following the report. That divergence highlights how sentiment, rather than a single data point, will likely determine whether the stock can build toward the target.
Several verified factors could support a climb. The balance sheet is unusually strong for a pre-profit company, with cash and investments equal to nearly 90% of the share price, providing a cushion against dilution risk and funding runway. Revenue is accelerating from a very low base, and management is transitioning products toward chip-scale TFLN manufacturing, which could improve margins and scalability. Analyst target revisions have been trending higher through 2026, with Ascendiant, Rosenblatt, and Lake Street all raising or maintaining above-average targets. Broader enthusiasm for quantum computing and photonics as a secular theme could also lift investor sentiment.
The obstacles are equally clear. QUBT is not yet profitable, and its earnings per share (EPS) remain negative on a trailing basis. Despite the triple-digit-percentage revenue growth, absolute revenue is still modest relative to a market capitalization above $1.5 billion, leaving the stock exposed to valuation compression if growth disappoints. The stock has declined sharply year to date in 2026, and the wide $10-to-$32 target spread signals that two of six analysts see meaningful downside risk. Competition in quantum and photonic technologies, along with any pullback in speculative technology sentiment, could keep shares well below $19.50.
The 52-week low near $5.39 and the roughly $5.67-per-share cash value identified by Rosenblatt form a notable support zone in the mid-$5 range. On the upside, the 52-week high near $14.45 marks a clear resistance area that the stock has not revisited, and the $19.50 target sits well above that prior peak. In other words, reaching the target would require not just a rebound but a decisive breakout to new highs, which is a structurally demanding path given the current downtrend in the share price.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms may differ. Investors should watch quarterly revenue growth and whether the company can sustain the recent acceleration, progress toward profitability, analyst target revisions, and any commentary on TFLN chip-scale production and commercial contracts. Broader shifts in risk appetite for speculative technology and quantum-themed names will also matter, as will any changes in the company's substantial cash position.
In my research on volatile names like QUBT, I frequently reference Tickeron’s AI Daily Buy/Sell Signals. The platform applies artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and market shifts. It serves as a practical complement to fundamental analysis, helping me spot potential trend changes without replacing my own due diligence.
The $19.50 target is the mean of six current analyst targets spanning $10 to $32, not a formal consensus or a forecast. From a price near $6.86, it implies a roughly 184% advance — a very large move that would require a breakout to new highs. The strongest supports are a cash-heavy balance sheet, accelerating revenue, and generally rising analyst targets, while the principal obstacles are persistent losses, a small absolute revenue base, a steep year-to-date decline, and wide analyst disagreement. Whether QUBT can reach $19.50 will ultimately depend on sustained revenue growth, progress toward profitability, and renewed investor confidence in the quantum technology theme.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Moving Average Convergence Divergence (MACD) for QUBT turned positive on November 09, 2026. Looking at past instances where QUBT's MACD turned positive, the stock continued to rise in 41 of 44 cases over the following month. The odds of a continued upward trend are 90%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where QUBT's RSI Indicator exited the oversold zone, 23 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 64 cases where QUBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on QUBT as a result. In 69 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
Following a +21.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUBT advanced for three days, in 193 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
QUBT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day moving average for QUBT crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for QUBT entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.900) is normal, around the industry mean (-6.197). QUBT's P/E Ratio (-158.250) is considerably lower than the industry average of (-3.670). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.994). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (169.492) is also within normal values, averaging (51.774).
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. QUBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerProcessingHardware